BenevolentAI SPAC Presentation Deck slide image

BenevolentAI SPAC Presentation Deck

Odyssey Acquisition - BenevolentAl's long-term partner Experienced and highly complementary team... Michael Zaoui - Chairman Founding Partner of Zaoui & Co 30+ years of M&A experience at Morgan Stanley (former Vice-Chairman) and Zaoui & Co Yoël Zaoui - co-CEO Found Partner of Zaoui & Co 30+ years of M&A experience at Goldman Sachs (former co-Head of Global M&A) and Zaoui & Co Jean Raby - co-CEO 30+ years as senior executive, banker and lawyer Former CEO of Natixis IM, CFO Alcatel-Lucent, Head investment banking Goldman Sachs FraBenelux and co-CEO of Russia and NY attorney (Sullivan & Cromwell) Dr. Olivier Brandicourt - Healthcare expert Senior Advisor at Blackstone Life Sciences ▪ 40+ years of Healthcare experience including as CEO of Sanofi-Aventis Michel Combes - Technology expert President of SoftBank Group International 35+ years of TMT experience including as CEO of Alcatel Lucent and Sprint . ZAOUI& Morgan Stanley ZAOUI& Goldman Sachs A Alcatel-Lucent Blackstone BAYER NATIXIS VESTMENT MANAGERS Goldman Sachs SoftBank Grap SANOFI Pfizer Alcatel-Lucent altice Sprint to support BenevolentAl's development over the long-run Deep Expertise and Leadership Experience in both Pharma and Technology ▪ Substantial experience leading pharma and technology companies through the various stages of their corporate lives . Well established track-record for value creation in pharma and technology through operational leadership and growth acceleration 2 Strong Financial and Deal-making Capabilities Long track-record advising companies on financial and capital markets matters Unique deal-making know-how focused on long-term strategic success and value maximisation ■ ■ 3 Extensive Network of Relationships Key strategic relationships with business leaders and corporate executives in pharma and technology Strong credibility with investors and demonstrated ability to attract capital . 4 Significant Long-Term Financial Commitment to BenevolentAl €300m capital raised to fund BenevolentAl's next stage of growth Significant financial investment from Odyssey's sponsors supporting their long-term commitment ▪ Two of Odyssey's sponsors to join BAI's Board of Directors I Benevolent 5
View entire presentation